
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss the rise of TV ads for specialty drugs, signs of life in the biotech IPO scene, and the case for Intercept Pharmaceuticals as a buyout target.
Pharma's TV blitz, biotech's IPO trickle, and the M&A future of Intercept Pharmaceuticals is an episode from FierceBiotech Radio. Fierce editors discuss the rise of TV ads for specialty drugs, signs of life in the biotech IPO scene, and the...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Feb 18, 2016, 39:23 long, audio available.
Fierce editors discuss the rise of TV ads for specialty drugs, signs of life in the biotech IPO scene, and the case for Intercept Pharmaceuticals as a buyout target.
You can listen to Pharma's TV blitz, biotech's IPO trickle, and the M&A future of Intercept Pharmaceuticals online on Radio and Podcast. Open the player on this page to stream the available audio.
Pharma's TV blitz, biotech's IPO trickle, and the M&A future of Intercept Pharmaceuticals is an episode from FierceBiotech Radio.
This episode is 39:23 long.
This episode was published on Feb 18, 2016.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from FierceBiotech Radio when more episodes are available from the podcast feed.
You can listen to Pharma's TV blitz, biotech's IPO trickle, and the M&A future of Intercept Pharmaceuticals on this page when the episode audio is available from the podcast feed.
Pharma's TV blitz, biotech's IPO trickle, and the M&A future of Intercept Pharmaceuticals is from FierceBiotech Radio.
Published Feb 18, 2016 and 39:23 long